DENVER INVESTMENT ADVISORS LLC - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 106 filers reported holding INTERSECT ENT INC in Q1 2017. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
DENVER INVESTMENT ADVISORS LLC ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q1 2018$573,000
+25.4%
14,570
+3.3%
0.03%
+30.4%
Q4 2017$457,000
+0.2%
14,104
-3.6%
0.02%
+4.5%
Q3 2017$456,000
-21.9%
14,635
-30.0%
0.02%
-15.4%
Q2 2017$584,000
+13.4%
20,905
-30.4%
0.03%
+13.0%
Q1 2017$515,000
+35.5%
30,030
-4.5%
0.02%
+43.8%
Q4 2016$380,00031,4400.02%
Other shareholders
INTERSECT ENT INC shareholders Q1 2017
NameSharesValueWeighting ↓
KOPP INVESTMENT ADVISORS LLC 238,698$3,781,0003.74%
PURA VIDA INVESTMENTS, LLC 275,000$4,356,0001.32%
Broadfin Capital, LLC 638,600$10,115,0000.91%
Aisling Capital LLC 248,498$3,936,0000.81%
Bellevue Group AG 205,325$3,252,0000.59%
Iguana Healthcare Management, LLC 180,000$2,852,0000.51%
Rock Springs Capital Management LP 345,000$5,465,0000.34%
SECTORAL ASSET MANAGEMENT INC 168,140$2,663,0000.26%
FORMULA GROWTH LTD 62,213$985,0000.22%
MENTA CAPITAL LLC 111,915$1,773,0000.17%
View complete list of INTERSECT ENT INC shareholders